US 6042829
Biotherapy of cancer by targeting TP-3/P80
expired A61KA61K47/6825A61P
Quick answer
US patent 6042829 (Biotherapy of cancer by targeting TP-3/P80) held by Regents of the University of Minnesota expires Mon Mar 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Regents of the University of Minnesota
- Grant date
- Tue Mar 28 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K47/6825, A61P, A61P35/00